Table 1. Characteristics of Patients .
| Patient | Gender | Age | Primary Disease | Diagnosis | Comorbidities | Smoke | BPT | Monoclonal Antibodies | Duration (mon) | Steroids | VIT D |
| AA | F | 80 | Breast cancer | 2013 | Hypertension | No | Zoledronate | - | 12 | Yes | No |
| BG | F | 74 | Breast cancer | No | Zoledronate | - | 18 | Yes | No | ||
| BGR | F | 67 | Breast cancer | 2010 | Yes | Zoledronate | - | 12 | No | No | |
| BGE | M | 67 | Pancreas cancer | Hypertension | Zoledronate | - | 5 | No | |||
| DLV | M | 70 | Prostate cancer | Zoledronate | - | 36 | |||||
| FN | F | 62 | Breast cancer | Zoledronate | - | ||||||
| FD | M | 60 | Kidney cancer | 2011 | - | No | Zoledronate | Sunitinib | 30 | ||
| GL | F | 85 | Osteoporosis- Reumatoid arthritis | Aritmia - Gastritis | Zoledronate | Denosumab | Yes | Yes | |||
| MA | F | 70 | Osteoporosis | Aledronate | - | ||||||
| MM | F | 70 | Osteoporosis | 2005 | Hypertension | Yes | Aledronate | - | 120 | No | No |
| MP | F | 72 | Osteoporosis | 2005 | Hypertension | No | Aledronate | - | 48 | No | Yes |
| PC | F | 77 | Osteoporosis | - | |||||||
| RD | F | 60 | Breast cancer | Zoledronate | - | ||||||
| SC | M | 81 | Prostate cancer | Zoledronate | - | 9 | Yes | No | |||
| SA | F | 76 | Osteoporosis | 2004 | Aledronate | - | 120 | ||||
| SC | F | 73 | Osteoporosis | 2000 | Hypertension | Aledronate | - | 164 | No | Yes | |
| SAM | F | 75 | Breast cancer | 1997 | Yes | Zoledronate | - | ||||
| TA | F | 75 | Osteoporosis | Hypertension | Aledronate | - | Yes | Yes | |||
| VS | M | 67 | Reumatoid arthritis | Aledronate | - | ||||||
| VIA | F | 75 | Osteoporosis | 2005 | Diabetes | No | Aledronate | - | 120 | Yes | Yes |
| ZL | F | 72 | Breast cancer | 2014 | Venous thrombosis | Zoledronate | - | 15 | No | Yes |